Header Ads

The next billion doses won't be easy

Here's the latest news from the global pandemic.

The next billion doses won't be easy

It took 61 days to give the first 100 million Covid-19 vaccine doses. The most recent 100 million was done in five. 

The world has crossed the 1 billion-dose threshold, a symbolic moment in the most ambitious public-health campaign in global history. Since the first shots were cleared for use in the U.K. on Dec. 2, that's more than 1 billion syringes, a billion alcohol-soaked cotton balls, a billion jabs to the skin and a billion tiny bandages. 

But if the first billion is the hardest, the next few billion won't be easy. It will take another 18 months to vaccinate 75% of the world's population at the current pace of 19.2 million shots a day. That's a level of inoculation that experts have said will beat back the virus and enable a return to normal.

To mark the 1 billion dose milestone, the Bloomberg Vaccine Tracker looked at the rollout so far and what comes next. It's an examination of which vaccines are being used in high-income countries versus those that are being deployed in less-wealthy places, how China and Russia have used vaccine exports to upend the global power order of the drug industry, and the early signs that the shots are beginning to affect outbreaks. 

The world has crossed the 1 billion dose threshold.

Photographer: Frederic J. Brown/AFP

In the U.S., the vaccine campaign is at a turning point after 229 million shots have been administered. More than half of all adults in the U.S. have had at least one dose. The eager and able have been vaccinated or will be soon. Those left, according to one state health official, are the "not able," the "not right now" and the "not ever."

That doesn't mean the Biden administration is ready to start giving away doses to the rest of the world. It's approaching the remainder of the rollout with the goal of vaccine abundance to inoculate those harder-to-reach people. And it's still wary that manufacturing problems or safety issues, as we've just seen with Johnson & Johnson's shot, mean the U.S. supply isn't locked down just yet. 

"We're obviously focused on taking care of Americans," a White House official told Bloomberg. "When we have the confidence in our supply, we'll definitely share."

You can read the full story here, with exclusive new data from our tracker about the shots going into arms around the world.—Drew Armstrong

Ask us anything

We want to know what you need to know. So ask us. Each week we will select one or two commonly asked questions and put them to our network of experts so you and your families can stay safe—and informed. Get in touch here or via CovidQs@bloomberg.net.
 

 

What you should read

U.S. Says It Will Send India Inoculation Materials
It joins European countries in pledging to help stem world's biggest surge.
All Vaccines Are Not Equal in the Travel Restart
Approval patchwork is laying the groundwork for global vaccine bifurcation.
Business Class Open to Masses as Covid Refuge
Passengers seek to minimize Covid risk in cheek-to-cheek jostle of coach.
Stop Vaccine 'Finger Wagging,' Says U.S. Official
Republican hesitancy seen as roadblock to achieving U.S. herd immunity.
Best and Worst Places to Be as Variants Rage
Singapore dethrones New Zealand in Bloomberg's Resilience Ranking.   

Know someone else who would like this newsletter? Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

No comments